Research News and Research

RSS

Researchers identify antiviral small molecule that is effective against numerous viruses

Viruses are insidious creatures. They differ from each other in many ways, and they can mutate - at times seemingly at will, as with HIV - to resist a host of weapons fired at them. Complicating matters further is that new viruses are constantly emerging.

2 Feb 2010

MCADD screening is expensive but offers immense health benefits

Newborn screening for a metabolic disorder could lead to false positives -- adding stress to parents, costing money and possibly subjecting a baby to unnecessary follow-up treatment and dietary restrictions.

2 Feb 2010

Stem Cell Therapy International completes merger with Histostem of South Korea

Stem Cell Therapy International, Inc. announced that it has completed its merger with Histostem Ltd. of South Korea ("Histostem"), forming one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a U.S. entity.

2 Feb 2010

New research shows tumor suppressor p53 prevents cancer progression in cells

Cells missegregate a chromosome approximately once every hundred divisions. But don't be too alarmed: new research in the Journal of Cell Biology shows that the tumor suppressor p53 limits the growth of cells with incorrect numbers of chromosomes and prevents their progression toward cancer.

2 Feb 2010

Evidence suggests antidepressants may improve post-stroke recovery

Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

2 Feb 2010

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

Canadian families managing Attention Deficit Hyperactivity Disorder (ADHD) have a new treatment option. Today, Shire plc, the global specialty biopharmaceutical company, announced the Canadian availability of VYVANSE (lisdexamfetamine dimesylate capsule), the first and only prodrug therapy approved for ADHD treatment in Canada.

2 Feb 2010

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Cellectricon AB today announced that it has resumed its litigation against Fluxion Biosciences, Inc. Cellectricon filed the lawsuit in July 2009 in the United States District Court for the Northern District of California alleging infringement of several United States patents issued or licensed to Cellectricon for microfluidic technology used in Cellectricon's state-of-the-art ion channel drug screening solution, the Dynaflow(R)HT System. Cellectricon's U.S. Patents Nos. 7,390,650, 7,470,518 and 7,563,614 have been asserted in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros, and licensed to Cellectricon.

From Fluxion Biosciences 2 Feb 2010

Thermo Fisher Scientific to acquire Finnzymes

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed a definitive agreement to acquire Finnzymes, a well-recognized provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Headquartered in Espoo, Finland, Finnzymes has 90 employees and generated revenue of $20 million in 2009.

From Thermo Fisher Scientific Inc. 2 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygiene

Ecolab Inc. today announced the launch of its new EnCompass™ Environmental Hygiene program, a comprehensive clinical program that helps hospitals improve patient room hygiene and prevent the spread of infections.

1 Feb 2010

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that the National Institutes of Health (NIH) awarded a grant to the University of Pittsburgh that includes funding of $350,000 over the grant period for WaferGen's SmartChip™ Real-Time PCR System. The researchers will conduct novel gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system as the key platform for high throughput validation.

1 Feb 2010

Children of Spanish-speaking Hispanic mothers spend less time in front of TV

Young children of Hispanic mothers whose dominant language is Spanish spend less time in front of the TV than children whose mothers speak mostly English, according to research led by investigators at Johns Hopkins Children's Center and published in the February issue of Archives of Pediatric & Adolescent Medicine.

1 Feb 2010

Danaher acquires AB SCIEX and Molecular Devices

Danaher Corporation announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices.

From Danaher 1 Feb 2010

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

Abbott announced today an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a pre-clinical monoclonal antibody identified at the Centre d'Immunologie Pierre Fabre (CIPF) in France and targeting the cMet receptor for the treatment of cancer.

1 Feb 2010

Denim blue jeans ribbon campaign: an initiative to raise awareness about children with rare diseases

Hope – It's In Our Genes.™ The Children's Rare Disease Network (http://www.crdnetwork.org) today announced the Global Genes Project (http://www.globalgenesproject.org), an initiative designed to raise awareness about the prevalence of rare diseases that afflict millions of children worldwide. Rare disease advocates organizing the campaign selected a blue jeans denim ribbon as the international symbol of hope for children suffering from life threatening and chronically debilitating rare diseases.

1 Feb 2010

ACE launches public service campaign to educate parents and teenagers on inhalant abuse

The Alliance for Consumer Education (ACE) is launching a new public service announcement campaign to support its www.inhalant.org website, and its ongoing efforts to reach out to parents and children about inhalant abuse.

1 Feb 2010

New testing method for early detection of cancer

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed.

1 Feb 2010

Belfast scientists identify gene that can help predict tamoxifen treatment failure

Scientists in Belfast have identified a gene which could predict whether women with breast cancer will respond to treatment with tamoxifen, according to findings published today in Cancer Research.

1 Feb 2010

Whole grain intake prevents diabetes, heart diseases, and excess weight gain

Three daily servings of whole grains are recommended for prevention of type 2 diabetes, coronary heart disease, and excess weight gain. Yet few adolescents or young adults follow these guidelines, according to national survey data. In a study published in the February 2010 issue of the Journal of the American Dietetic Association, researchers from the School of Public Health, University of Minnesota report that young people are consuming less than 1 serving of whole grains per day. The study took an in-depth look at influencers, modifiable factors, and interventions that are critical for successfully addressing this gap.

1 Feb 2010

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women’s Hospital, the H. Lee Moffitt Cancer Center, Dartmouth’s Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.

1 Feb 2010

Research News and Research

Researchers identify antiviral small molecule that is effective against numerous viruses

MCADD screening is expensive but offers immense health benefits

Stem Cell Therapy International completes merger with Histostem of South Korea

New research shows tumor suppressor p53 prevents cancer progression in cells

Evidence suggests antidepressants may improve post-stroke recovery

Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment

Cellectricon resumes litigation against Fluxion Biosciences over alleged patent infringement

Thermo Fisher Scientific to acquire Finnzymes

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Ecolab launches EnCompass Environmental Hygiene program to improve patient room hygiene

University of Pittsburgh awarded $3.5M NIH grant for WaferGen Biosystems's SmartChip Real-Time PCR System

Children of Spanish-speaking Hispanic mothers spend less time in front of TV

Danaher acquires AB SCIEX and Molecular Devices

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

Denim blue jeans ribbon campaign: an initiative to raise awareness about children with rare diseases

ACE launches public service campaign to educate parents and teenagers on inhalant abuse

New testing method for early detection of cancer

Belfast scientists identify gene that can help predict tamoxifen treatment failure

Whole grain intake prevents diabetes, heart diseases, and excess weight gain

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News